Oxytocin and suicide risk: a study for women with suicidal thoughts
Treatments studied
Part of Mental health clinical trials.
This study tests whether a dose of oxytocin (a natural brain chemical) affects how you see yourself and whether that relates to suicide risk. You would visit the lab twice, fast for 10 hours before one visit, and get either oxytocin or a placebo.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 40 years old
- You were born female and have a regular menstrual cycle of 26–30 days
- You have some degree of self-dehumanization (feeling less than human) and current suicidal thoughts
- You are not afraid of needles
- You can go without food for 10 hours (water is allowed)
- You do not have a psychosis diagnosis and are not at immediate risk of suicide
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a hormone called oxytocin affects feelings of self-worth and suicide risk. It involves a nasal spray and blood draws to measure oxytocin levels, and may help find new ways to support people who have had suicidal thoughts.
This study looks at how a hormone called oxytocin affects the brain's reward system in women. If you are a healthy woman with a natural menstrual cycle or on birth control pills, you may be able to join and help researchers understand how oxytocin influences emotions and motivation.
This study checks whether tiny genetic signals in blood (microRNAs) are linked to childhood maltreatment and thoughts or risk of suicide, especially in people with major depression. It may help researchers understand biological clues that could someday guide better care.
This trial tests whether adding oxytocin (a hormone that helps with social bonding) to group therapy can improve symptoms and social functioning in people with schizophrenia. It compares two different doses of oxytocin to see which works better.
This study looks at how depression, bipolar disorder, and suicide risk naturally change over time. It aims to better understand these conditions so doctors can improve treatments.
This Phase 2 trial tests whether oxytocin (a hormone-like medication) can reduce binge-eating symptoms in adults with binge-eating disorder (including related conditions like bulimia or certain feeding/eating disorders). You may be eligible if your symptoms match the trial’s specific diagnosis rules and you can safely take the study medication.
Hear when a new Rehumanization Intervention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.